Drug interactions
Dinutuximab beta + Immunoglobulin
Severity: Moderate
Dinutuximab beta and Immunoglobulin: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Intravenous immunoglobulin may interfere with the antibody-dependent cytotoxicity that mediates dinutuximab beta activity. This could reduce antitumor effect.
What this interaction means in plain words
Dinutuximab beta and Immunoglobulin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Dinutuximab beta belongs to Oncology; Immunoglobulin belongs to Miscellaneous.
Why it happens
Immunoglobulin may compete for Fc receptor engagement, impairing ADCC.
What to do
Avoid routine IVIG during dinutuximab beta treatment unless clearly indicated, and consider timing separation.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Dinutuximab beta and Immunoglobulin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Immunoglobulin
- Immunoglobulin + Pozelimab Major
- Efgartigimod alfa + Immunoglobulin Moderate
- Immunoglobulin + Nipocalimab Moderate
- Immunoglobulin + Rozanolixizumab Moderate
Frequently asked questions
Can I take Dinutuximab beta with Immunoglobulin?
MediHelp rates the interaction as moderate. Dinutuximab beta and Immunoglobulin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Intravenous immunoglobulin may interfere with the antibody-dependent cytotoxicity that mediates dinutuximab beta activity. This could reduce antitumor effect.
How serious is the interaction between Dinutuximab beta and Immunoglobulin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid routine IVIG during dinutuximab beta treatment unless clearly indicated, and consider timing separation.
What other medicines interact with Immunoglobulin?
MediHelp also lists interactions of Immunoglobulin with, for example, Pozelimab, Efgartigimod alfa, Nipocalimab. The full list is on the Immunoglobulin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
